Skip Navigation
Skip to contents

Journal of Microbiology : Journal of Microbiology

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse Articles > Author index
Search
Shukho Kim 8 Articles
Characterization of a Salmonella Enteritidis bacteriophage showing broad lytic activity against Gram-negative enteric bacteria
Shukho Kim , Sung-Hun Kim , Marzia Rahman , Jungmin Kim
J. Microbiol. 2018;56(12):917-925.   Published online October 25, 2018
DOI: https://doi.org/10.1007/s12275-018-8310-1
  • 355 View
  • 0 Download
  • 31 Crossref
AbstractAbstract PDF
In this study, we sought to isolate Salmonella Enteritidis-specific lytic bacteriophages (phages), and we found a lytic phage that could lyse not only S. Enteritidis but also other Gramnegative foodborne pathogens. This lytic phage, SS3e, could lyse almost all tested Salmonella enterica serovars as well as other enteric pathogenic bacteria including Escherichia coli, Shigella sonnei, Enterobacter cloacae, and Serratia marcescens. This SS3e phage has an icosahedral head and a long tail, indicating belong to the Siphoviridae. The genome was 40,793 base pairs, containing 58 theoretically determined open reading frames (ORFs). Among the 58 ORFs, ORF49, and ORF25 showed high sequence similarity with tail spike protein and lysozyme-like protein of Salmonella phage SE2, respectively, which are critical proteins recognizing and lysing host bacteria. Unlike SE2 phage whose host restricted to Salmonella enterica serovars Enteritidis and Gallinarum, SS3e showed broader host specificity against Gram-negative enteric bacteria; thus, it could be a promising candidate for the phage utilization against various Gram-negative bacterial infection including foodborne pathogens.

Citations

Citations to this article as recorded by  
  • Isolation and characterization of Salmonella enteritidis bacteriophage Salmp-p7 isolated from slaughterhouse effluent and its application in food
    Mengge Chen, Tong Yu, Xiangyu Cao, Jiaqi Pu, Deshu Wang, Hongkuan Deng
    Archives of Microbiology.2025;[Epub]     CrossRef
  • Two novel polyvalent phages: a promising approach for cross-order pathogen control in aquaculture
    Chengcheng Li, Yufei Yue, Rui Yin, Jiulong Zhao, Zengmeng Wang, Shailesh Nair, Yongyu Zhang
    Virology Journal.2025;[Epub]     CrossRef
  • Isolation and characterization of virulent bacteriophages and controlling Salmonella Enteritidis biofilms on chicken meat
    Xiaowen Sun, Fan Xue, Cong Cong, Bilal Murtaza, Chenxi Guo, Haochen Su, Xiaoyu Li, Lili Wang, Yongping Xu
    Microbial Pathogenesis.2025; 205: 107619.     CrossRef
  • Optimizing phage therapy for carbapenem-resistant Enterobacter cloacae bacteremia: insights into dose and timing
    Shi-Yong Fu, Xiu-Zhen Chen, Peng-Cheng Yi, Jie Gao, Wei-Xiao Wang, Shuang-Lin Gu, Jing-Han Gao, Du-Xian Liu, Han-Feng Xu, Yi Zeng, Chun-Mei Hu, Qin Zheng, Wei Chen, Pranita D. Tamma
    Antimicrobial Agents and Chemotherapy.2025;[Epub]     CrossRef
  • Therapeutic potential of novel phages with antibiotic combinations against ESBL-producing and carbapenem-resistant Escherichia Coli
    Md Shamsuzzaman, Shukho Kim, Jungmin Kim
    Journal of Global Antimicrobial Resistance.2025; 43: 86.     CrossRef
  • In vitro, genomic characterization and pre-clinical evaluation of a new thermostable lytic Obolenskvirus phage formulated as a hydrogel against carbapenem-resistant Acinetobacter baumannii
    Mahmoud M. Sherif, Neveen A. Abdelaziz, Mohammad Y. Alshahrani, Sarra E. Saleh, Khaled M. Aboshanab
    Scientific Reports.2025;[Epub]     CrossRef
  • Phage therapy as a promising solution for food safety: isolation and biological characterization of bacteriophage P2 for controlling Salmonella enterica infections
    Tran Khang Nam, Pham Thi Lanh, Man Hong Phuoc, Dong Van Quyen
    Academia Journal of Biology.2025; 47(2): 53.     CrossRef
  • Combating multidrug-resistant uropathogenic E. coli using lytic phages, enhancing antibiotic synergy and inhibiting biofilms
    Md Shamsuzzaman, Yoon-Jung Choi, Shukho Kim, Jungmin Kim
    International Microbiology.2025;[Epub]     CrossRef
  • Can natural preservatives serve as a new line of protective technology against bacterial pathogens in meat and meat products?
    Changyong Cheng, Lingli Jiang, Xiaoliang Li, Houhui Song, Weihuan Fang
    Food Quality and Safety.2024;[Epub]     CrossRef
  • Bacteriophage as a novel therapeutic approach for killing multidrug-resistant Escherichia coli ST131 clone
    Md Shamsuzzaman, Shukho Kim, Jungmin Kim
    Frontiers in Microbiology.2024;[Epub]     CrossRef
  • Characterization of two virulent Salmonella phages and transient application in egg, meat and lettuce safety
    XiaoWen Sun, Fan Xue, Cong Cong, Bilal Murtaza, LiLi Wang, XiaoYu Li, ShuYing Li, YongPing Xu
    Food Research International.2024; 190: 114607.     CrossRef
  • Advanced strategies to overcome the challenges of bacteriophage-based antimicrobial treatments in food and agricultural systems
    Shanshan Liu, Siew-Young Quek, Kang Huang
    Critical Reviews in Food Science and Nutrition.2024; 64(33): 12574.     CrossRef
  • Review of phage display: A jack-of-all-trades and master of most biomolecule display
    Brenda Pei Chui Song, Angela Chiew Wen Ch'ng, Theam Soon Lim
    International Journal of Biological Macromolecules.2024; 256: 128455.     CrossRef
  • Application of the lytic bacteriophage Rostam to control Salmonella enteritidis in eggs
    Rahim Azari, Mohammad Hashem Yousefi, Zohreh Taghipour, Jeroen Wagemans, Rob Lavigne, Saeid Hosseinzadeh, Seyed Mohammad Mazloomi, Marta Vallino, Sepideh Khalatbari-Limaki, Enayat Berizi
    International Journal of Food Microbiology.2023; 389: 110097.     CrossRef
  • Isolation and genomic characterization of Vmp-1 using Vibrio mimicus as the host: A novel virulent bacteriophage capable of cross-species lysis against three Vibrio spp.
    Bin Yang, Yang Wang, Lu Gao, Sheng-qi Rao, Wen-yuan Zhou, Zhen-quan Yang, Xin-an Jiao, Benjamin Kumah Mintah, Mokhtar Dabbour
    Microbial Pathogenesis.2023; 174: 105948.     CrossRef
  • A Review on the Antimicrobial Effect of Honey on Salmonella and Listeria monocytogenes: Recent Studies
    Fatih Ramazan İSTANBULLUGİL, Nuri TAŞ, Ulaş ACARÖZ, Damla ARSLAN-ACAROZ, Ömer ÇAKMAK, Sezen EVRENKAYA, Zeki GÜRLER
    Manas Journal of Agriculture Veterinary and Life Sciences.2023; 13(2): 210.     CrossRef
  • Characterization of a Diverse Collection of Salmonella Phages Isolated from Tennessee Wastewater
    Daniel W. Bryan, Lauren K. Hudson, Jia Wang, Thomas G. Denes
    PHAGE.2023; 4(2): 90.     CrossRef
  • Newly Isolated Virulent Salmophages for Biocontrol of Multidrug-Resistant Salmonella in Ready-to-Eat Plant-Based Food
    Michał Wójcicki, Olga Świder, Paulina Średnicka, Dziyana Shymialevich, Tomasz Ilczuk, Łukasz Koperski, Hanna Cieślak, Barbara Sokołowska, Edyta Juszczuk-Kubiak
    International Journal of Molecular Sciences.2023; 24(12): 10134.     CrossRef
  • Prevalence of Indigenous Antibiotic-Resistant Salmonella Isolates and Their Application to Explore a Lytic Phage vB_SalS_KFSSM with an Intra-Broad Specificity
    Jaein Choe, Su-Hyeon Kim, Ji Min Han, Jong-Hoon Kim, Mi-Sun Kwak, Do-Won Jeong, Mi-Kyung Park
    Journal of Microbiology.2023; 61(12): 1063.     CrossRef
  • Statistical optimization of a podoviral anti-MRSA phage CCASU-L10 generated from an under sampled repository: Chicken rinse
    Israa M. Abd-Allah, Ghadir S. El-Housseiny, Mohamed H. Al-Agamy, Hesham H. Radwan, Khaled M. Aboshanab, Nadia A. Hassouna
    Frontiers in Cellular and Infection Microbiology.2023;[Epub]     CrossRef
  • Characterization and Genome Study of a Newly Isolated Temperate Phage Belonging to a New Genus Targeting Alicyclobacillus acidoterrestris
    Dziyana Shymialevich, Michał Wójcicki, Olga Świder, Paulina Średnicka, Barbara Sokołowska
    Genes.2023; 14(6): 1303.     CrossRef
  • An Anti-MRSA Phage From Raw Fish Rinse: Stability Evaluation and Production Optimization
    Israa M. Abd-Allah, Ghadir S. El-Housseiny, Mohammad Y. Alshahrani, Samar S. El-Masry, Khaled M. Aboshanab, Nadia A. Hassouna
    Frontiers in Cellular and Infection Microbiology.2022;[Epub]     CrossRef
  • Anti-Salmonella polyvinyl alcohol coating containing a virulent phage PBSE191 and its application on chicken eggshell
    Sangbin Kim, Yoonjee Chang
    Food Research International.2022; 162: 111971.     CrossRef
  • Applications of bacteriophages against intracellular bacteria
    Paulina Śliwka, Marta Ochocka, Aneta Skaradzińska
    Critical Reviews in Microbiology.2022; 48(2): 222.     CrossRef
  • In Vitro and In Vivo Gastrointestinal Survival of Non-Encapsulated and Microencapsulated Salmonella Bacteriophages: Implications for Bacteriophage Therapy in Poultry
    Laura Lorenzo-Rebenaque, Danish J. Malik, Pablo Catalá-Gregori, Clara Marin, Sandra Sevilla-Navarro
    Pharmaceuticals.2021; 14(5): 434.     CrossRef
  • How Broad Is Enough: The Host Range of Bacteriophages and Its Impact on the Agri-Food Sector
    Karen Fong, Catherine W.Y. Wong, Siyun Wang, Pascal Delaquis
    PHAGE.2021; 2(2): 83.     CrossRef
  • Characterization and Application of a Lytic Phage D10 against Multidrug-Resistant Salmonella
    Zhiwei Li, Wanning Li, Wenjuan Ma, Yifeng Ding, Yu Zhang, Qile Yang, Jia Wang, Xiaohong Wang
    Viruses.2021; 13(8): 1626.     CrossRef
  • Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa
    Shukho Kim, Da-Won Lee, Jong-Sook Jin, Jungmin Kim
    Journal of Global Antimicrobial Resistance.2020; 22: 32.     CrossRef
  • Characterization of the narrow-spectrum bacteriophage LSE7621 towards Salmonella Enteritidis and its biocontrol potential on lettuce and tofu
    Aiping Liu, Yilin Liu, Lin Peng, Xingzhe Cai, Li Shen, Maoping Duan, Yu Ning, Shuliang Liu, Chunyan Li, Yuntao Liu, Hong Chen, Wenjuan Wu, Xiaohong Wang, Bin Hu, Cheng Li
    LWT.2020; 118: 108791.     CrossRef
  • State of the Art in the Culture of the Human Microbiota: New Interests and Strategies
    Maryam Tidjani Alou, Sabrina Naud, Saber Khelaifia, Marion Bonnet, Jean-Christophe Lagier, Didier Raoult
    Clinical Microbiology Reviews.2020;[Epub]     CrossRef
  • Lytic KFS-SE2 phage as a novel bio-receptor for Salmonella Enteritidis detection
    In Young Choi, Cheonghoon Lee, Won Keun Song, Sung Jae Jang, Mi-Kyung Park
    Journal of Microbiology.2019; 57(2): 170.     CrossRef
Inverse PCR for subtyping of Acinetobacter baumannii carrying ISAba1
Shukho Kim , Yun-Ju Park , Jungmin Kim
J. Microbiol. 2016;54(5):376-380.   Published online April 20, 2016
DOI: https://doi.org/10.1007/s12275-016-6038-3
  • 344 View
  • 0 Download
  • 3 Crossref
AbstractAbstract PDF
Acinetobacter baumannii has been prevalent in nosocomial infections, often causing outbreaks in intensive care units. ISAba1 is an insertion sequence that has been identified only in A. baumannii and its copy number varies among strains. It has been reported that ISAba1 provides a promoter for blaOXA-51-like, blaOXA-23-like, and blaampC, which are associated with the resistance of A. baumannii to carbapenems and cephalosporins. The main purpose of this study was to develop a novel inverse PCR method capable of typing A. baumannii strains. The method involves three major steps: cutting of genomic DNA with a restriction enzyme, ligation, and PCR. In the first step, bacterial genomic DNA was digested with DpnI. In the second step, the digested genomic DNAs were ligated to form intramolecular circular DNAs. In the last step, the ligated circular DNAs were amplified by PCR with primers specific for ISAba1 and the amplified PCR products were electrophoresed. Twenty-two clinical isolates of A. baumannii were used for the evaluation of the inverse PCR (iPCR) typing method. Dendrogram analysis revealed two major clusters, similar to pulsed-field gel electrophoresis (PFGE) results. Three ISAba1-associated genes – blaampC, blaOXA-66-like, and csuD – were amplified and detected in the clinical isolates. This novel iPCR typing method is comparable to PFGE in its ability to discriminate A. baumannii strains, and is a promising molecular epidemiological tool for investigating A. baumannii carrying ISAba1.

Citations

Citations to this article as recorded by  
  • DNA sonication inverse PCR for genome scale analysis of uncharacterized flanking sequences
    David E. Alquezar‐Planas, Ulrike Löber, Pin Cui, Claudia Quedenau, Wei Chen, Alex D. Greenwood, Susan Johnston
    Methods in Ecology and Evolution.2021; 12(1): 182.     CrossRef
  • Update on the Epidemiological Typing Methods for Acinetobacter Baumannii
    Rayane Rafei, Marwan Osman, Fouad Dabboussi, Monzer Hamze
    Future Microbiology.2019; 14(12): 1065.     CrossRef
  • Identification and characterization of a novel cold-tolerant extracellular protease from Planococcus sp. CGMCC 8088
    Kun Chen, Qingshan Mo, Huan Liu, Feiyan Yuan, Haonan Chai, Fuping Lu, Huitu Zhang
    Extremophiles.2018; 22(3): 473.     CrossRef
Antibacterial Efficacy of Lytic Pseudomonas Bacteriophage in Normal and Neutropenic Mice Models
Birendra R. Tiwari , Shukho Kim , Marzia Rahman , Jungmin Kim
J. Microbiol. 2011;49(6):994-999.   Published online December 28, 2011
DOI: https://doi.org/10.1007/s12275-011-1512-4
  • 214 View
  • 0 Download
  • 72 Crossref
AbstractAbstract PDF
Recently, lytic bacteriophages (phages) have been focused on treating bacterial infectious diseases. We investigated the protective efficacy of a novel Pseudomonas aeruginosa phage, PA1Ø, in normal and neutropenic mice. A lethal dose of P. aeruginosa PAO1 was administered via the intraperitoneal route and a single dose of PA1Ø with different multiplicities of infection (MOI) was treated into infected mice. Immunocompetent mice infected with P. aeruginosa PAO1 were successfully protected by PA1Ø of 1 MOI, 10 MOI or 100 MOI with 80% to 100% survival rate. No viable bacteria were found in organ samples after 48 h of the phage treatment. Phage clearing patterns were different in the presence or absence of host bacteria but PA1Ø disappeared from all organs after 72 h except spleen in the presence of host bacteria. On the contrary, PA1Ø treatment could not protect neutropenic mice infected with P. aeruginosa PAO1 even though could extend their lives for a short time. In in vitro phage-neutrophil bactericidal test, a stronger bactericidal effect was observed in phage-neutrophil co-treatment than in phage single treatment without neutrophils, suggesting phage-neutrophil co-work is essential for the efficient killing of bacteria in the mouse model. In conclusion, PA1Ø can be possibly utilized in future phage therapy endeavors since it exhibited strong protective effects against virulent P. aeruginosa infection.

Citations

Citations to this article as recorded by  
  • Isolation and characterization of a potent bacteriophage KA targeting an antibiotic-resistant human pathogenic strain of Klebsiella pneumoniae KP1
    Aneela Nawaz, Nauman Ahmed Khalid, Sidra Zaheer, Muhammad Ismail Khan, Ali Khalid, Aamer Ali Shah, Malik Badshah, Samiullah Khan
    Microbial Pathogenesis.2026; 210: 108150.     CrossRef
  • Phage-induced protection against lethal bacterial reinfection
    Yikun Xing, Haroldo J. Hernandez Santos, Ling Qiu, Samantha R. Ritter, Jacob J. Zulk, Rachel Lahowetz, Kathryn A. Patras, Austen L. Terwilliger, Anthony W. Maresso
    Proceedings of the National Academy of Sciences.2025;[Epub]     CrossRef
  • Bacteriophages as an alternative strategy for the treatment of drug resistant bacterial infections: Current approaches and future perspectives
    Abayeneh Girma
    The Cell Surface.2025; 14: 100149.     CrossRef
  • Multi-strain phage induced clearance of bacterial infections
    Jacopo Marchi, Chau Nguyen Ngoc Minh, Laurent Debarbieux, Joshua S Weitz, Rob J De Boer
    PLOS Computational Biology.2025; 21(2): e1012793.     CrossRef
  • Overcoming Pseudomonas aeruginosa in Chronic Suppurative Lung Disease: Prevalence, Treatment Challenges, and the Promise of Bacteriophage Therapy
    Jagdev Singh, Melinda Solomon, Jonathan Iredell, Hiran Selvadurai
    Antibiotics.2025; 14(5): 427.     CrossRef
  • Isolation and identification of a newly discovered broad-spectrum Acinetobacter baumannii phage and therapeutic validation against pan-resistant Acinetobacter baumannii
    Miaomiao Lin, Lele Xiong, Wen Li, Lingyan Xiao, Wei Zhang, Xiaogui Zhao, Yishan Zheng
    Virologica Sinica.2025; 40(4): 587.     CrossRef
  • Overcoming antimicrobial resistance: Phage therapy as a promising solution to combat ESKAPE pathogens
    Ritu Raj Patel, Pandey Priya Arun, Sudhir Kumar Singh, Meenakshi Singh
    International Journal of Antimicrobial Agents.2025; 66(6): 107640.     CrossRef
  • Phage-mediated TLR2 signaling attenuates intracellular Mycobacterium abscessus survival in macrophages
    Hannah Kapoor, Aaron M. Maves, Madeline A. Bowder, Lia Danelishvili
    Scientific Reports.2025;[Epub]     CrossRef
  • Neutrophils, not macrophages, aid phage-mediated control of pulmonary Pseudomonas aeruginosa infection
    Chantal Weissfuss, Karen Hoffmann, Ulrike Behrendt, Magdalena Bürkle, Shailey G. Twamley, Imke H. E. Korf, Katharina Ahrens, Christine Rohde, Christian M. Zobel, Laurent Debarbieux, Jean-Damien Ricard, Martin Witzenrath, Geraldine Nouailles
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • Mycobacteriophages: therapeutic approach for mycobacterial infections
    Sunil Kumar Raman, D.V. Siva Reddy, Vikas Jain, Urmi Bajpai, Amit Misra, Amit Kumar Singh
    Drug Discovery Today.2024; 29(7): 104049.     CrossRef
  • Pseudomonas aeruginosa Bacteriophages and Their Clinical Applications
    Elaheh Alipour-Khezri, Mikael Skurnik, Gholamreza Zarrini
    Viruses.2024; 16(7): 1051.     CrossRef
  • Exploiting lung adaptation and phage steering to clear pan-resistant Pseudomonas aeruginosa infections in vivo
    Eleri A. Ashworth, Rosanna C. T. Wright, Rebecca K. Shears, Janet K. L. Wong, Akram Hassan, James P. J. Hall, Aras Kadioglu, Joanne L. Fothergill
    Nature Communications.2024;[Epub]     CrossRef
  • Phage-inspired strategies to combat antibacterial resistance
    Mianzhi Wang, Junxuan Zhang, Jingyi Wei, Lei Jiang, Li Jiang, Yongxue Sun, Zhenling Zeng, Zhiqiang Wang
    Critical Reviews in Microbiology.2024; 50(2): 196.     CrossRef
  • Bacteriophages isolated from mouse feces attenuates pneumonia mice caused by Pseudomonas aeruginosa
    Nuttawut Sutnu, Wiwat Chancharoenthana, Supitcha Kamolratanakul, Pornpimol Phuengmaung, Uthaibhorn Singkham-In, Chiratchaya Chongrak, Sirikan Montathip, Dhammika Leshan Wannigama, Tanittha Chatsuwan, Puey Ounjai, Marcus J. Schultz, Asada Leelahavanichkul,
    PLOS ONE.2024; 19(7): e0307079.     CrossRef
  • Evaluation of the impact of repeated intravenous phage doses on mammalian host–phage interactions
    Xin Tan, Kai Chen, Zhihuan Jiang, Ziqiang Liu, Siyun Wang, Yong Ying, Jieqiong Zhang, Shengjian Yuan, Zhipeng Huang, Ruyue Gao, Min Zhao, Aoting Weng, Yongqing Yang, Huilong Luo, Daizhou Zhang, Yingfei Ma, Kristin N. Parent
    Journal of Virology.2024;[Epub]     CrossRef
  • The contribution of neutrophils to bacteriophage clearance and pharmacokinetics in vivo
    Arne Echterhof, Tejas Dharmaraj, Arya Khosravi, Robert McBride, Lynn Miesel, Ju-Hsin Chia, Patrick M. Blankenberg, Kun-Yuan Lin, Chien-Chang Shen, Yu-Ling Lee, Yu-Chuan Yeh, Wei Ting Liao, Francis G. Blankenberg, Krystyna Dąbrowska, Derek F. Amanatullah,
    JCI Insight.2024;[Epub]     CrossRef
  • In vivo safety evaluation and tracing of arginylglycylaspartic acid-engineered phage nanofiber in murine model
    Kshitiz Raj Shrestha, Sehoon Kim, Anna Jo, Murali Ragothaman, So Young Yoo
    Journal of Materials Chemistry B.2024; 12(40): 10258.     CrossRef
  • Metapopulation model of phage therapy of an acute Pseudomonas aeruginosa lung infection
    Rogelio A. Rodriguez-Gonzalez, Quentin Balacheff, Laurent Debarbieux, Jacopo Marchi, Joshua S. Weitz, Oleg A. Igoshin
    mSystems.2024;[Epub]     CrossRef
  • Pharmacokinetics and Biodistribution of Phages and their Current Applications in Antimicrobial Therapy
    Dayeon Kang, Damayanti Bagchi, Irene A. Chen
    Advanced Therapeutics.2024;[Epub]     CrossRef
  • Phage therapy: A primer for orthopaedic trauma surgeons
    Baixing Chen, T.Fintan Moriarty, Willem-Jan Metsemakers, Marco Chittò
    Injury.2024; 55: 111847.     CrossRef
  • Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections
    Maria Siopi, Dimitrios Skliros, Paschalis Paranos, Nikoletta Koumasi, Emmanouil Flemetakis, Spyros Pournaras, Joseph Meletiadis, Graeme N. Forrest
    Clinical Microbiology Reviews.2024;[Epub]     CrossRef
  • Phage-Based Therapy in Combination with Antibiotics: A Promising Alternative against Multidrug-Resistant Gram-Negative Pathogens
    Cleo Anastassopoulou, Stefanos Ferous, Aikaterini Petsimeri, Georgia Gioula, Athanasios Tsakris
    Pathogens.2024; 13(10): 896.     CrossRef
  • Leveraging mathematical modeling framework to guide regimen strategy for phage therapy
    Zhiyuan Yu, Tiffany Luong, Selenne Banuelos, Andrew Sue, Hwayeon Ryu, Rebecca Segal, Dwayne R. Roach, Qimin Huang, Jaehee Kim
    PLOS Complex Systems.2024; 1(3): e0000015.     CrossRef
  • Phage therapy: a revolutionary shift in the management of bacterial infections, pioneering new horizons in clinical practice, and reimagining the arsenal against microbial pathogens
    Subhash Lal Karn, Mayank Gangwar, Rajesh Kumar, Satyanam Kumar Bhartiya, Gopal Nath
    Frontiers in Medicine.2023;[Epub]     CrossRef
  • A novel lytic phage exhibiting a remarkable in vivo therapeutic potential and higher antibiofilm activity against Pseudomonas aeruginosa
    Aliaa Abdelghafar, Amira El-Ganiny, Ghada Shaker, Momen Askoura
    European Journal of Clinical Microbiology & Infectious Diseases.2023; 42(10): 1207.     CrossRef
  • Phage-host-immune system dynamics in bacteriophage therapy: basic principles and mathematical models
    Dongwoo Chae
    Translational and Clinical Pharmacology.2023; 31(4): 167.     CrossRef
  • BACTERIOPHAGE M13 MODULATES THE SEPSIS-RELATED INFLAMMATORY RESPONSES AND ORGAN DAMAGE IN A CLP MODEL
    Arezou Rahimi, Sara Soudi, Saeid Vakilian, Fatemeh Jamshidi-Adegani, Majid Sadeghizadeh, Sulaiman Al-Hashmi
    Shock.2023; 59(3): 493.     CrossRef
  • Human Neutrophil Response to Pseudomonas Bacteriophage PAK_P1, a Therapeutic Candidate
    Dwayne R. Roach, Benoît Noël, Sylvie Chollet-Martin, Mathieu de Jode, Vanessa Granger, Laurent Debarbieux, Luc de Chaisemartin
    Viruses.2023; 15(8): 1726.     CrossRef
  • Translating phage therapy into the clinic: Recent accomplishments but continuing challenges
    Aleksandra Petrovic Fabijan, Jonathan Iredell, Katarzyna Danis-Wlodarczyk, Razieh Kebriaei, Stephen T. Abedon
    PLOS Biology.2023; 21(5): e3002119.     CrossRef
  • Phage therapy for hidradenitis suppurativa: a unique challenge and possible opportunity for personalized treatment of a complex, inflammatory disease
    Lene Bens, Sabrina I Green, Daan Jansen, Tom Hillary, Tine Vanhoutvin, Jelle Matthijnssens, João Sabino, Séverine Vermeire, An Van Laethem, Jeroen Wagemans, Rob Lavigne
    Clinical and Experimental Dermatology.2023; 48(11): 1221.     CrossRef
  • Determination of phage load and administration time in simulated occurrences of antibacterial treatments
    Steffen Plunder, Markus Burkard, Ulrich M. Lauer, Sascha Venturelli, Luigi Marongiu
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations
    Georgia Mitropoulou, Angela Koutsokera, Chantal Csajka, Sylvain Blanchon, Alain Sauty, Jean-Francois Brunet, Christophe von Garnier, Grégory Resch, Benoit Guery
    European Respiratory Review.2022; 31(166): 220121.     CrossRef
  • Modification of the immune response by bacteriophages alters methicillin-resistant Staphylococcus aureus infection
    Tomoya Suda, Tomoko Hanawa, Mayuko Tanaka, Yasunori Tanji, Kazuhiko Miyanaga, Sanae Hasegawa-Ishii, Ken Shirato, Takako Kizaki, Takeaki Matsuda
    Scientific Reports.2022;[Epub]     CrossRef
  • Bacteriophage: A new therapeutic player to combat neutrophilic inflammation in chronic airway diseases
    Daniel R. Laucirica, Stephen M. Stick, Luke W. Garratt, Anthony Kicic
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Therapeutic Bacteriophages for Gram-Negative Bacterial Infections in Animals and Humans
    Panagiotis Zagaliotis, Jordyn Michalik-Provasek, Jason Gill, Thomas Walsh
    Pathogens and Immunity.2022; 7(2): 1.     CrossRef
  • Circulation of Fluorescently Labelled Phage in a Murine Model
    Zuzanna Kaźmierczak, Joanna Majewska, Magdalena Milczarek, Barbara Owczarek, Krystyna Dąbrowska
    Viruses.2021; 13(2): 297.     CrossRef
  • Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Pseudomonas aeruginosa Infections
    Dana Holger, Razieh Kebriaei, Taylor Morrisette, Katherine Lev, Jose Alexander, Michael Rybak
    Antibiotics.2021; 10(5): 556.     CrossRef
  • Characteristics of a Bacteriophage, vB_Kox_ZX8, Isolated From Clinical Klebsiella oxytoca and Its Therapeutic Effect on Mice Bacteremia
    Ping Li, Yangheng Zhang, Fuhua Yan, Xin Zhou
    Frontiers in Microbiology.2021;[Epub]     CrossRef
  • Reapproaching Old Treatments: Considerations for PK/PD Studies on Phage Therapy for Bacterial Respiratory Infections
    Alan A. Schmalstig, Soha Freidy, Patrick O. Hanafin, Miriam Braunstein, Gauri G. Rao
    Clinical Pharmacology & Therapeutics.2021; 109(6): 1443.     CrossRef
  • A single dose of a virulent bacteriophage vB PaeP-SaPL, rescues bacteremic mice infected with multi drug resistant Pseudomonas aeruginosa
    Iqbal Ahmad Alvi, Muhammad Asif, Shafiq ur Rehman
    Virus Research.2021; 292: 198250.     CrossRef
  • Antiviral effect of a bacteriophage on murine norovirus replication via modulation of the innate immune response
    Lili Zhang, Chang Ma, Jie Liu, Khashayar Shahin, Xiang Hou, Lichang Sun, Heye Wang, Ran Wang
    Virus Research.2021; 305: 198572.     CrossRef
  • Bacteriophages as an Alternative Method for Control of Zoonotic and Foodborne Pathogens
    Mohammed Mijbas Mohammed Alomari, Marta Dec, Renata Urban-Chmiel
    Viruses.2021; 13(12): 2348.     CrossRef
  • Formulation strategies for bacteriophages to target intracellular bacterial pathogens
    Wei Yan, Parikshit Banerjee, Miao Xu, Subhankar Mukhopadhyay, Margaret Ip, Nicholas B. Carrigy, David Lechuga-Ballesteros, Kenneth Kin Wah To, Sharon S.Y. Leung
    Advanced Drug Delivery Reviews.2021; 176: 113864.     CrossRef
  • Characterization of a Novel Bacteriophage Henu2 and Evaluation of the Synergistic Antibacterial Activity of Phage-Antibiotics
    Xianghui Li, Tongxin Hu, Jiacun Wei, Yuhua He, Abualgasim Elgaili Abdalla, Guoying Wang, Yanzhang Li, Tieshan Teng
    Antibiotics.2021; 10(2): 174.     CrossRef
  • Therapeutic Perspectives and Mechanistic Insights of Phage Therapy in Allotransplantation
    Kenneth J. Dery, Andrzej Górski, Ryszard Międzybrodzki, Douglas G. Farmer, Jerzy W. Kupiec-Weglinski
    Transplantation.2021; 105(7): 1449.     CrossRef
  • How to kill Pseudomonas—emerging therapies for a challenging pathogen
    Luke N. Yaeger, Victoria E. Coles, Derek C. K. Chan, Lori L. Burrows
    Annals of the New York Academy of Sciences.2021; 1496(1): 59.     CrossRef
  • Bacteriophages and the Immune System
    Medeea Popescu, Jonas D. Van Belleghem, Arya Khosravi, Paul L. Bollyky
    Annual Review of Virology.2021; 8(1): 415.     CrossRef
  • Synergistic Killing and Re-Sensitization of Pseudomonas aeruginosa to Antibiotics by Phage-Antibiotic Combination Treatment
    Emily Engeman, Helen R. Freyberger, Brendan W. Corey, Amanda M. Ward, Yunxiu He, Mikeljon P. Nikolich, Andrey A. Filippov, Stuart D. Tyner, Anna C. Jacobs
    Pharmaceuticals.2021; 14(3): 184.     CrossRef
  • Pharmacokinetics and Pharmacodynamics of a Novel Virulent Klebsiella Phage Kp_Pokalde_002 in a Mouse Model
    Gunaraj Dhungana, Roshan Nepal, Madhav Regmi, Rajani Malla
    Frontiers in Cellular and Infection Microbiology.2021;[Epub]     CrossRef
  • Interactions of Bacteriophages with Animal and Human Organisms—Safety Issues in the Light of Phage Therapy
    Magdalena Podlacha, Łukasz Grabowski, Katarzyna Kosznik-Kawśnicka, Karolina Zdrojewska, Małgorzata Stasiłojć, Grzegorz Węgrzyn, Alicja Węgrzyn
    International Journal of Molecular Sciences.2021; 22(16): 8937.     CrossRef
  • A Review of Using Mathematical Modeling to Improve Our Understanding of Bacteriophage, Bacteria, and Eukaryotic Interactions
    Kathryn M. Styles, Aidan T. Brown, Antonia P. Sagona
    Frontiers in Microbiology.2021;[Epub]     CrossRef
  • Impact of Frequent Administration of Bacteriophage on Therapeutic Efficacy in an A. baumannii Mouse Wound Infection Model
    Michael D. Rouse, Joshua Stanbro, Jessica A. Roman, Michelle A. Lipinski, Anna Jacobs, Biswaijt Biswas, James Regeimbal, Matthew Henry, Michael G. Stockelman, Mark P. Simons
    Frontiers in Microbiology.2020;[Epub]     CrossRef
  • Phage therapy efficacy: a review of the last 10 years of preclinical studies
    Luís D. R. Melo, Hugo Oliveira, Diana P. Pires, Krystyna Dabrowska, Joana Azeredo
    Critical Reviews in Microbiology.2020; 46(1): 78.     CrossRef
  • RLP, a bacteriophage of the family Podoviridae, rescues mice from bacteremia caused by multi-drug-resistant Pseudomonas aeruginosa
    Iqbal Ahmad Alvi, Muhammad Asif, Rabia Tabassum, Rehan Aslam, Zaigham Abbas, Shafiq ur Rehman
    Archives of Virology.2020; 165(6): 1289.     CrossRef
  • Pf Bacteriophage and Their Impact on Pseudomonas Virulence, Mammalian Immunity, and Chronic Infections
    Patrick R. Secor, Elizabeth B. Burgener, M. Kinnersley, Laura K. Jennings, Valery Roman-Cruz, Medeea Popescu, Jonas D. Van Belleghem, Naomi Haddock, Conner Copeland, Lia A. Michaels, Christiaan R. de Vries, Qingquan Chen, Julie Pourtois, Travis J. Wheeler
    Frontiers in Immunology.2020;[Epub]     CrossRef
  • Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies
    Mihnea R. Mangalea, Breck A. Duerkop, Karen M. Ottemann
    Infection and Immunity.2020;[Epub]     CrossRef
  • Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review
    Krystyna Dąbrowska
    Medicinal Research Reviews.2019; 39(5): 2000.     CrossRef
  • Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies
    Krystyna Dąbrowska, Stephen T. Abedon
    Microbiology and Molecular Biology Reviews.2019;[Epub]     CrossRef
  • Biological challenges of phage therapy and proposed solutions: a literature review
    Katherine M Caflisch, Gina A Suh, Robin Patel
    Expert Review of Anti-infective Therapy.2019; 17(12): 1011.     CrossRef
  • Interactions between Bacteriophage, Bacteria, and the Mammalian Immune System
    Jonas D. Van Belleghem, Krystyna Dąbrowska, Mario Vaneechoutte, Jeremy J. Barr, Paul L. Bollyky
    Viruses.2018; 11(1): 10.     CrossRef
  • Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder Formulation
    Rachel Yoon Kyung Chang, Ke Chen, Jiping Wang, Martin Wallin, Warwick Britton, Sandra Morales, Elizabeth Kutter, Jian Li, Hak-Kim Chan
    Antimicrobial Agents and Chemotherapy.2018;[Epub]     CrossRef
  • Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Pseudomonas aeruginosa in Cystic Fibrosis. An Argumentative Review
    Martina Rossitto, Ersilia V. Fiscarelli, Paola Rosati
    Frontiers in Microbiology.2018;[Epub]     CrossRef
  • Phage-Phagocyte Interactions and Their Implications for Phage Application as Therapeutics
    Ewa Jończyk-Matysiak, Beata Weber-Dąbrowska, Barbara Owczarek, Ryszard Międzybrodzki, Marzanna Łusiak-Szelachowska, Norbert Łodej, Andrzej Górski
    Viruses.2017; 9(6): 150.     CrossRef
  • Modeling the synergistic elimination of bacteria by phage and the innate immune system
    Chung Yin (Joey) Leung, Joshua S. Weitz
    Journal of Theoretical Biology.2017; 429: 241.     CrossRef
  • Characterization and complete genome sequence analysis of two Myoviral bacteriophages infecting clinical carbapenem‐resistant Acinetobacter baumannii isolates
    J. Jeon, R. D'Souza, N. Pinto, C.‐M. Ryu, J. Park, D. Yong, K. Lee
    Journal of Applied Microbiology.2016; 121(1): 68.     CrossRef
  • Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections
    Diana P. Pires, Diana Vilas Boas, Sanna Sillankorva, Joana Azeredo, S. P. Goff
    Journal of Virology.2015; 89(15): 7449.     CrossRef
  • The Effect of Bacteriophage Preparations on Intracellular Killing of Bacteria by Phagocytes
    Ewa Jończyk-Matysiak, Marzanna Łusiak-Szelachowska, Marlena Kłak, Barbara Bubak, Ryszard Międzybrodzki, Beata Weber-Dąbrowska, Maciej Żaczek, Wojciech Fortuna, Paweł Rogóż, Sławomir Letkiewicz, Krzysztof Szufnarowski, Andrzej Górski
    Journal of Immunology Research.2015; 2015: 1.     CrossRef
  • Bacteriophages and Biofilms
    David Harper, Helena Parracho, James Walker, Richard Sharp, Gavin Hughes, Maria Werthén, Susan Lehman, Sandra Morales
    Antibiotics.2014; 3(3): 270.     CrossRef
  • Phage fitness may help predict phage therapy efficacy
    Heather M Lindberg, Kurt A McKean, Ing-Nang Wang
    Bacteriophage.2014; 4(4): e964081.     CrossRef
  • Bacteriophages and Their Derivatives as Biotherapeutic Agents in Disease Prevention and Treatment
    Mohamed Elbreki, R. Paul Ross, Colin Hill, Jim O'Mahony, Olivia McAuliffe, Aidan Coffey
    Journal of Viruses.2014; 2014: 1.     CrossRef
  • Phage Therapy Is Effective against Infection by Mycobacterium ulcerans in a Murine Footpad Model
    Gabriela Trigo, Teresa G. Martins, Alexandra G. Fraga, Adhemar Longatto-Filho, António G. Castro, Joana Azeredo, Jorge Pedrosa, Christian Johnson
    PLoS Neglected Tropical Diseases.2013; 7(4): e2183.     CrossRef
  • Use of bacteriophages in the treatment ofPseudomonas aeruginosainfections
    James Soothill
    Expert Review of Anti-infective Therapy.2013; 11(9): 909.     CrossRef
Interaction of Acinetobacter baumannii 19606 and 1656-2 with Acanthamoeba castellanii
Migma Dorji Tamang , Shukho Kim , Sung-Min Kim , Hyun-Hee Kong , Jungmin Kim
J. Microbiol. 2011;49(5):841-846.   Published online November 9, 2011
DOI: https://doi.org/10.1007/s12275-011-1063-8
  • 190 View
  • 0 Download
  • 8 Crossref
AbstractAbstract PDF
Acinetobacter baumannii is virtually avirulent for healthy people but maintains a high virulence among critically ill patients or immuno-compromised individuals. The ability of A. baumannii to adhere to cells and persist on surfaces as biofilms could be central to its pathogenicity. In the present study, we compared the virulence of the A. baumannii 1656-2 clinical strain, which is able to form a thick biofilm, with the virulence of the A. baumannii type strain (ATCC 19606T). Acanthamoeba castellanii, a single-celled organism, was used as the host model system to study the virulence of A. baumannii. Compared to A. baumannii ATCC 19606T, A. baumannii 1656-2 exhibited a higher ability to adhere and invade A. castellanii cells and had a higher killing rate of A. castellanii cells. Furthermore, co-incubation of the amoeba cells and the cell-free supernatant of A. baumannii resulted in the cell death of the amoebae. Heat inactivation or proteinase K treatment of the supernatant did not eliminate its cytotoxicity, suggesting heat stable non-protein factors are responsible for its cytotoxicity to A. castellanii cells. In conclusion, this study for the first time has revealed the capacity of the A. baumannii strain and/or its metabolic products to induce cytotoxicity in A. castellanii cells.

Citations

Citations to this article as recorded by  
  • The intracellular life of Acinetobacter baumannii
    Alexandra Maure, Etienne Robino, Charles Van der Henst
    Trends in Microbiology.2023; 31(12): 1238.     CrossRef
  • Molecular screening and characterization of Legionella pneumophila associated free-living amoebae in domestic and hospital water systems
    Muhammad Atif Nisar, Kirstin E Ross, Melissa H Brown, Richard Bentham, Jason Hinds, Harriet Whiley
    Water Research.2022; 226: 119238.     CrossRef
  • Interaction of Staphylococcus aureus and Acinetobacter baumannii during In Vitro β-Lactam Exposure
    Nicholas M. Smith, Alexa Ang, Fanny Tan, Katelyn Macias, Sarah James, Jasleen Sidhu, Justin R. Lenhard
    Antimicrobial Agents and Chemotherapy.2021;[Epub]     CrossRef
  • Environmental Free-Living Amoebae Can Predate on Diverse Antibiotic-Resistant Human Pathogens
    Félix Bornier, Eline Zas, Damien Potheret, Maria-Halima Laaberki, Bénédicte Coupat-Goutaland, Xavier Charpentier, Christopher A. Elkins
    Applied and Environmental Microbiology.2021;[Epub]     CrossRef
  • A Tractable Drosophila Cell System Enables Rapid Identification of Acinetobacter baumannii Host Factors
    Qing-Ming Qin, Jianwu Pei, Gabriel Gomez, Allison Rice-Ficht, Thomas A. Ficht, Paul de Figueiredo
    Frontiers in Cellular and Infection Microbiology.2020;[Epub]     CrossRef
  • Genomic analysis of a Raoultella ornithinolytica strain causing prosthetic joint infection in an immunocompetent patient
    Mamadou Beye, Issam Hasni, Piseth Seng, Caroline Michelle, Bernard La Scola, Didier Raoult, Pierre-Edouard Fournier
    Scientific Reports.2018;[Epub]     CrossRef
  • Current and Past Strategies for Bacterial Culture in Clinical Microbiology
    Jean-Christophe Lagier, Sophie Edouard, Isabelle Pagnier, Oleg Mediannikov, Michel Drancourt, Didier Raoult
    Clinical Microbiology Reviews.2015; 28(1): 208.     CrossRef
  • Acanthamoeba and bacteria produce antimicrobials to target their counterpart
    Junaid Iqbal, Ruqaiyyah Siddiqui, Naveed Ahmed Khan
    Parasites & Vectors.2014;[Epub]     CrossRef
Providencia Isolates Carrying blaPER-1 and blaVIM-2 Genes: Biofilm-Forming Capacity and Biofilm Inhibitory Concentrations for Carbapenem Antibiotics
Jungmin Kim , Shukho Kim , Hee Woo Lee , Sung Min Kim , Sung Yong Seol
J. Microbiol. 2011;49(3):512-515.   Published online June 30, 2011
DOI: https://doi.org/10.1007/s12275-011-1221-z
  • 173 View
  • 0 Download
AbstractAbstract PDF
Multidrug-resistant clinical isolates of Providencia carrying blaPER-1 and blaVIM-2 were evaluated for the abilities to form biofilm and high biofilm forming capacity was demonstrated in them. Minimum biofilm inhibitory concentrations (MBICs), minimum biofilm eradication concentrations (MBECs), and minimum inhibitory concentrations (MICs) for imipenem and meropenem were also determined. In all tested strains, the MBICs were higher than the MICs for both drugs. Interestingly, the MBICs and the MBEC50 for meropenem were lower than those for imipenem in the isolates producing high amounts of biofilm, suggesting that meropenem is superior to imipenem in the growth inhibition and eradication of biofilm forming Providencia strains.
A Simple Colorimetric Method for Testing Antimicrobial Susceptibility of Biofilmed Bacteria
Shukho Kim , Mi Jin Kim , Hee Young Kang , Sung Yong Seol , Dong Taek Cho , Jungmin Kim
J. Microbiol. 2010;48(5):709-711.   Published online November 3, 2010
DOI: https://doi.org/10.1007/s12275-010-0299-z
  • 248 View
  • 0 Download
  • 21 Crossref
AbstractAbstract PDF
This study introduces a simple colorimetric method which can measure the antimicrobial susceptibility of bacteria in biofilms using trimethyl tetrazolium chloride (TTC) as an indicator of viable bacteria. The new method was utilized for the evaluation of antibiotic susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus biofilms.

Citations

Citations to this article as recorded by  
  • Antibiofilm and Antimicrobial Potentials of Novel Synthesized Sulfur Camphor Derivatives
    Anna Duda-Madej, Szymon Viscardi, Katarzyna Pacyga, Robert Kupczyński, Wanda Mączka, Małgorzata Grabarczyk, Paweł Pacyga, Ewa Topola, Michał Ostrówka, Jacek Bania, Antoni Szumny, Katarzyna Wińska
    International Journal of Molecular Sciences.2024; 25(20): 10895.     CrossRef
  • Bioadhesives with Antimicrobial Properties
    Mustafa Nakipoglu, Ayşen Tezcaner, Christopher H. Contag, Nasim Annabi, Nureddin Ashammakhi
    Advanced Materials.2023;[Epub]     CrossRef
  • The impact of biosynthesized ZnO nanoparticles from Olea europaea (Common Olive) on Pseudomonas aeruginosa growth and biofilm formation
    Hafez Al-Momani, Dua’a Al Balawi, Saja Hamed, Borhan Aldeen Albiss, Muna Almasri, Hadeel AlGhawrie, Lujain Ibrahim, Hadeel Al Balawi, Sameer Al Haj Mahmoud, Jeffrey Pearson, Christopher Ward
    Scientific Reports.2023;[Epub]     CrossRef
  • Does Secondary Plant Metabolite Ursolic Acid Exhibit Antibacterial Activity against Uropathogenic Escherichia coli Living in Single- and Multispecies Biofilms?
    Zuzanna Sycz, Dorota Wojnicz, Dorota Tichaczek-Goska
    Pharmaceutics.2022; 14(8): 1691.     CrossRef
  • Are Uropathogenic Bacteria Living in Multispecies Biofilm Susceptible to Active Plant Ingredient—Asiatic Acid?
    Zuzanna Sycz, Dorota Tichaczek-Goska, Anna Jezierska-Domaradzka, Dorota Wojnicz
    Biomolecules.2021; 11(12): 1754.     CrossRef
  • Antibacterial activities of and biofilm removal by Ablysin, an endogenous lysozyme-like protein originated from Acinetobacter baumannii 1656-2
    Shukho Kim, Jong-Sook Jin, Da-Won Lee, Jungmin Kim
    Journal of Global Antimicrobial Resistance.2020; 23: 297.     CrossRef
  • Antibacterial action of nitric oxide-releasing hyperbranched polymers against ex vivo dental biofilms
    Lei Yang, Flavia Teles, Weida Gong, Shawn A. Dua, Lynn Martin, Mark H. Schoenfisch
    Dental Materials.2020; 36(5): 635.     CrossRef
  • Susceptibility to biofilm formation on 3D-printed titanium fixation plates used in the mandible: a preliminary study
    Lukasz Palka, Justyna Mazurek-Popczyk, Katarzyna Arkusz, Katarzyna Baldy-Chudzik
    Journal of Oral Microbiology.2020; 12(1): 1838164.     CrossRef
  • Anti-biofilm effects and characterisation of the hydrogen peroxide activity of a range of Western Australian honeys compared to Manuka and multifloral honeys
    Azhar Sindi, Moses Van Bawi Chawn, Magda Escorcia Hernandez, Kathryn Green, Md Khairul Islam, Cornelia Locher, Katherine Hammer
    Scientific Reports.2019;[Epub]     CrossRef
  • Functional assessment of microbial superoxide dismutase isozymes suggests a differential role for each isozyme
    Hastyar Najmuldeen, Rashed Alghamdi, Fayez Alghofaili, Hasan Yesilkaya
    Free Radical Biology and Medicine.2019; 134: 215.     CrossRef
  • Polymicrobial Biofilm Inhibition Effects of Acetate‐Buffered Chitosan Sponge Delivery Device
    Jessica Amber Jennings, Karen E. Beenken, Ashley C. Parker, James Keaton Smith, Harry S. Courtney, Mark S. Smeltzer, Warren O. Haggard
    Macromolecular Bioscience.2016; 16(4): 591.     CrossRef
  • Chronic Wound Biofilms: Pathogenesis and Potential Therapies
    Allie Clinton, Tammy Carter
    Laboratory Medicine.2015; 46(4): 277.     CrossRef
  • Isolation and characterization of an Enterococcus faecalis bacteriophage
    Hee-Young Kang, Shukho Kim, Jungmin Kim
    The Korean Journal of Microbiology.2015; 51(3): 194.     CrossRef
  • Effects of Azithromycin, Metronidazole, Amoxicillin, and Metronidazole plus Amoxicillin on anIn VitroPolymicrobial Subgingival Biofilm Model
    Geisla M. S. Soares, Flavia Teles, Jacqueline R. Starr, Magda Feres, Michele Patel, Lynn Martin, Ricardo Teles
    Antimicrobial Agents and Chemotherapy.2015; 59(5): 2791.     CrossRef
  • Pyocyanin Stimulates Quorum Sensing-Mediated Tolerance to Oxidative Stress and Increases Persister Cell Populations in Acinetobacter baumannii
    Nidhi Bhargava, Prince Sharma, Neena Capalash, B. A. McCormick
    Infection and Immunity.2014; 82(8): 3417.     CrossRef
  • Optimization of tetrazolium salt assay for Pseudomonas aeruginosa biofilm using microtiter plate method
    Parastoo Sabaeifard, Ahya Abdi-Ali, Mohammad Reza Soudi, Rasoul Dinarvand
    Journal of Microbiological Methods.2014; 105: 134.     CrossRef
  • Study of 2,3,5-Triphenyltetrazolium Chloride for Detection of Pathogenic Microorganisms
    Jung Wook Kang, Jun Tae Bae, Jae Young Yeon, Young Ho Kim, Jin Hwa Kim, Geun Soo Lee, Hyeong Bae Pyo
    Journal of the Society of Cosmetic Scientists of Korea.2014; 40(3): 307.     CrossRef
  • Pseudomonas aeruginosa Bacteriophage PA1Ø Requires Type IV Pili for Infection and Shows Broad Bactericidal and Biofilm Removal Activities
    Shukho Kim, Marzia Rahman, Sung Yong Seol, Sang Sun Yoon, Jungmin Kim
    Applied and Environmental Microbiology.2012; 78(17): 6380.     CrossRef
  • The inhibitory effect of phloretin on the formation of Escherichia coli O157:H7 biofilm in a microfluidic system
    Aeri Park, Heon-Ho Jeong, Jintae Lee, Chang-Soo Lee
    BioChip Journal.2012; 6(3): 299.     CrossRef
  • Characterization of inducedStaphylococcus aureusbacteriophage SAP-26 and its anti-biofilm activity with rifampicin
    Marzia Rahman, Shukho Kim, Sung Min Kim, Sung Yong Seol, Jungmin Kim
    Biofouling.2011; 27(10): 1087.     CrossRef
  • Providencia isolates carrying bla PER-1 and bla VIM-2 genes: Biofilm-forming capacity and biofilm inhibitory concentrations for carbapenem antibiotics
    Jungmin Kim, Shukho Kim, Hee Woo Lee, Sung Min Kim, Sung Yong Seol
    The Journal of Microbiology.2011; 49(3): 512.     CrossRef
Phage Types and Pulsed-Field Gel Electrophoresis Patterns of Salmonella enterica serovar Enteritidis Isolated from Humans and Chickens
Sung Hun Kim , Shukho Kim , Sung Guen Chun , Mi-Sun Park , Jeong Hyun Park , Bok-Kwon Lee
J. Microbiol. 2008;46(2):209-213.   Published online June 11, 2008
DOI: https://doi.org/10.1007/s12275-007-0197-1
  • 228 View
  • 0 Download
  • 14 Crossref
AbstractAbstract PDF
We analyzed 66 Salmonella Enteritidis isolates in 2002. Thirty isolates were obtained from human patients with diarrhea, and 36 were obtained from chickens. A total of ten phage types (PT) were identified in the human and chicken isolates. PT1 and PT21 were the predominant PTs in both the human (20% and 13%) and chicken (17% and 47%) isolates. Twelve pulsotypes were generated by PFGE and divided into two major groups. Most of the PFGE types were categorized into cluster group 1. Eighteen chicken isolates in cluster group 1 showed high-level genetic association (>95%) with 22 other human isolates. Additionally, six chicken isolates from cluster group 2 showed fairly high-level genetic association (>95%) with the other seven human isolates. The highest levels of genetic association in humans and chickens were seen with A5-PT21 (11 isolates), A2-PT1 (7 isolates), and B1-PT4 (6 isolates). The Pulsed-Field Gel Electrophoresis (PFGE) and phage typing provided conclusive evidence that human Salmonella infections are attributable to the consumption of contaminated chicken.

Citations

Citations to this article as recorded by  
  • Advanced strategies to overcome the challenges of bacteriophage-based antimicrobial treatments in food and agricultural systems
    Shanshan Liu, Siew-Young Quek, Kang Huang
    Critical Reviews in Food Science and Nutrition.2024; 64(33): 12574.     CrossRef
  • Characterization of a Salmonella Enteritidis bacteriophage showing broad lytic activity against Gram-negative enteric bacteria
    Shukho Kim, Sung-Hun Kim, Marzia Rahman, Jungmin Kim
    Journal of Microbiology.2018; 56(12): 917.     CrossRef
  • Public health significance of major genotypes of Salmonella enterica serovar Enteritidis present in both human and chicken isolates in Korea
    Min-Su Kang, Jae-Young Oh, Yong-Kuk Kwon, Deog-Yong Lee, Ok-Mi Jeong, Byung-Kook Choi, So-Youn Youn, Byung-Woo Jeon, Hye-Jin Lee, Hee-Soo Lee
    Research in Veterinary Science.2017; 112: 125.     CrossRef
  • Enumeration and Characterization ofSalmonellaIsolates from Retail Chicken Carcasses in Beijing, China
    Yeru Wang, Qian Chen, Shenghui Cui, Xiao Xu, Jianghui Zhu, Haipeng Luo, Di Wang, Fengqin Li
    Foodborne Pathogens and Disease.2014; 11(2): 126.     CrossRef
  • Characterization ofSalmonellaEnteritidis strains isolated from poultry and farm environments in Brazil
    F. CAMPIONI, M. M. ZOLDAN, J. P. FALCÃO
    Epidemiology and Infection.2014; 142(7): 1403.     CrossRef
  • Antimicrobial Resistance in Invasive Non-typhoid Salmonella from the Democratic Republic of the Congo: Emergence of Decreased Fluoroquinolone Susceptibility and Extended-spectrum Beta Lactamases
    Octavie Lunguya, Veerle Lejon, Marie-France Phoba, Sophie Bertrand, Raymond Vanhoof, Youri Glupczynski, Jan Verhaegen, Jean-Jacques Muyembe-Tamfum, Jan Jacobs, Stephen Baker
    PLoS Neglected Tropical Diseases.2013; 7(3): e2103.     CrossRef
  • Serotypes, antimicrobial resistance of Salmonella spp. and plasmid profiles, phage types, PFGE of S. Enteritidis and S. Typhimurium isolated from ducks in Daegu-Gyeongbuk province
    Jae-Keun Cho, Min-Su Kang, Ki-Seuk Kim
    Korean Journal of Veterinary Service.2011; 34(3): 217.     CrossRef
  • Antibiotic Resistance in Salmonella Isolates from Imported Chicken Carcasses in Bhutan and from Pig Carcasses in Vietnam
    L. Ellerbroek, D. Narapati, N. Phu Tai, N. Poosaran, R. Pinthong, A. Sirimalaisuwan, P. Tshering, R. Fries, K.-H. Zessin, M. Baumann, A. Schroeter
    Journal of Food Protection.2010; 73(2): 376.     CrossRef
  • SalmonellaSerovars from Foodborne and Waterborne Diseases in Korea, 1998-2007: Total Isolates Decreasing Versus Rare Serovars Emerging
    Shukho Kim
    Journal of Korean Medical Science.2010; 25(12): 1693.     CrossRef
  • Seroprevalence of Swine Salmonellosis in Korean Swine Herds
    Yeong-Hun Kim, Ill-Kyong Kwon, Jeong-Hee Han
    Korean Journal for Food Science of Animal Resources.2010; 30(1): 62.     CrossRef
  • Isolation of Salmonella enterica in Laying-Hen Flocks and Assessment of Eggshell Contamination in France
    Marianne Chemaly, Adeline Huneau-Salaün, Annie Labbe, Catherine Houdayer, Isabelle Petetin, Philippe Fravalo
    Journal of Food Protection.2009; 72(10): 2071.     CrossRef
  • Functional and molecular characterization of pSE34 encoding a type IV secretion system inSalmonella entericaserotype Enteritidis phage type 34
    Chyi-Liang Chen, Chen-Yu Wang, Chishih Chu, Lin-Hui Su, Cheng-Hsun Chiu
    FEMS Immunology & Medical Microbiology.2009; 57(3): 274.     CrossRef
  • Influence of lingual orthodontic therapy on microbial parameters and periodontal status in adults
    A. Demling, C. Demling, R. Schwestka-Polly, M. Stiesch, W. Heuer
    The European Journal of Orthodontics.2009; 31(6): 638.     CrossRef
  • Genotypic and Phenotypic Diversity of Salmonella Enteritidis Isolated from Chickens and Humans in Korea
    Zheng-Wu KANG, Ji-Hun JUNG, Sung Hun KIM, Bok Kwon LEE, Duk Young LEE, Young Jo KIM, Ji Youn LEE, Ho-Keun WON, Eun Hee KIM, Tae-Wook HAHN
    Journal of Veterinary Medical Science.2009; 71(11): 1433.     CrossRef
Genomic Relationship of Salmonella enterica Serovar Typhimurium DT104 Isolates from Korea and the United States
Shukho Kim , Sung Guen Chun , Ok Young Lim , Mi Sun Park , Yeon Ho Kang , Yong Ho Park , Bok Kwon Lee
J. Microbiol. 2004;42(1):14-19.
DOI: https://doi.org/2007 [pii]
  • 214 View
  • 0 Download
AbstractAbstract PDF
Salmonella enterica serovar Typhimurium DT104 (Salmonella Typhimurium DT104 or DT104) hasbeen emerging as a common pathogen for human in Korea since 1997. In order to compare the genomic relationship and to search for the dominant strains in Korea, we conducted pulsed-field gel electrophoresis (PFGE) and IS200 fingerprinting of 25 epidemiological unrelated isolates from human and animals from Korea and cattle from America. Two Salmonella Typhimurium DT104 isolates from human in Korea and all 8 isolates from American cattle had indistinguishable patterns from the PFGE and IS200 fingerprinting but multidrug-resistant Salmonella Typhimurium isolates, including DT104, from Korean animals had diverse genetic patterns. The data suggest that a dominant DT104 strain might have circulated between Korean and American cattle and that it had a high level of clonality.
Shukho Kim 1 Article
Characterization of Newly Isolated Bacteriophages Targeting Carbapenem-Resistant Klebsiella pneumoniae
Bokyung Kim, Shukho Kim, Yoon-Jung Choi, Minsang Shin, Jungmin Kim
J. Microbiol. 2024;62(12):1133-1153.   Published online December 10, 2024
DOI: https://doi.org/10.1007/s12275-024-00180-7
  • 396 View
  • 9 Download
  • 1 Web of Science
  • 2 Crossref
AbstractAbstract PDF
Klebsiella pneumoniae, a Gram-negative opportunistic pathogen, is increasingly resistant to carbapenems in clinical settings. This growing problem necessitates the development of alternative antibiotics, with phage therapy being one promising option. In this study, we investigated novel phages targeting carbapenem-resistant Klebsiella pneumoniae (CRKP) and evaluated their lytic capacity against clinical isolates of CRKP. First, 23 CRKP clinical isolates were characterized using Multi-Locus Sequence Typing (MLST), carbapenemase test, string test, and capsule typing. MLST classified the 23 K. pneumoniae isolates into 10 sequence types (STs), with the capsule types divided into nine known and one unknown type. From sewage samples collected from a tertiary hospital, 38 phages were isolated. Phenotypic and genotypic characterization of these phages was performed using Random Amplification of Polymorphic DNA-PCR (RAPD-PCR), transmission electron microscopy (TEM), and whole genome sequencing (WGS) analysis. Host spectrum analysis revealed that each phage selectively lysed strains sharing the same STs as their hosts, indicating ST-specific activity. These phages were subtyped based on their host spectrum and RAPD-PCR, identifying nine and five groups, respectively. Fourteen phages were selected for further analysis using TEM and WGS, revealing 13 Myoviruses and one Podovirus. Genomic analysis grouped the phages into three clusters: one closely related to Alcyoneusvirus, one to Autographiviridae, and others to Straboviridae. Our results showed that the host spectrum of K. pneumoniae-specific phages corresponds to the STs of the host strain. These 14 novel phages also hold promise as valuable resources for phage therapy against CRKP.

Citations

Citations to this article as recorded by  
  • Evaluation of Bacteriophage and Antibiotic Synergy Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates
    Bokyung Kim, Shukho Kim, Yoon-Jung Choi, Minsang Shin, Jungmin Kim
    Journal of Bacteriology and Virology.2025; 55(2): 131.     CrossRef
  • Possible regulatory network and associated pathways governing the expression of ADH2 in Saccharomyces cerevisiae
    Pratima Sarkar, Rohan Nath, Prity Adhikary, Arindam Bhattacharjee
    Current Genetics.2025;[Epub]     CrossRef

Journal of Microbiology : Journal of Microbiology
TOP